HighTower Advisors
COCP icon

HighTower Advisors’s Cocrystal Pharma COCP Stock Holding History

HighTower Advisors’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,250
Closed -$66K – 3327
2021
Q3 		$66K Sell
5,250
-2,333
-31% -$30.9K ﹤0.01% 2907
2021
Q2 		$114K Buy
7,583
+4,583
+153% +$69.7K ﹤0.01% 2785
2021
Q1 		$50K Buy
3,000
+408
+16% +$8.29K ﹤0.01% 2834
2020
Q4 		$42K Buy
+2,592
New +$36K ﹤0.01% 2425

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

HighTower Advisors's COCP Position: Q4 2021 in Review

HighTower Advisors sold out of Cocrystal Pharma (COCP) in Q4 2021, closing a stake of 5,250 shares — an estimated $66K sold.

HighTower Advisors first reported a position in COCP in Q4 2020 and held it in 4 quarters. The position peaked at $114K in Q2 2021. 35 funds tracked by Wall St. Rank hold COCP as of Q4 2021.

  • HighTower Advisors reported no remaining Cocrystal Pharma position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 5,250 Cocrystal Pharma shares in Q4 2021, an estimated $66K.
  • HighTower Advisors first reported a position in Cocrystal Pharma in Q4 2020 and held it in 4 quarters.
  • HighTower Advisors's Cocrystal Pharma position peaked at $114K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.